The Regulatory Outlook for Future Vaccine Adjuvants
Norman W. Baylor, Ph.D., President and CEO, Biologics Consulting Group, Inc.
Synthetic Genomics to Address Emerging Threats and Global Supply Challenges
Bolyn Hubby, Ph.D., Senior Director, Head, Vaccine and Phage R&D, Synthetic Genomics Vaccines, Inc.
Putting Cancer in Check with Novel Immunomodulatory Strategies
Michael A. Postow, M.D., Assistant Attending Physician, Melanoma and Immunotherapeutics Service, Memorial Sloan-Kettering Cancer Center
Update from 2014 ASCO Meeting: Clinical Trials for Immunotherapy Combinations
Omid Hamid, M.D., Director, Melanoma Center, Angeles Clinic and Research Institute
CAR T Cells from the Mouse Cage to the Patients’ Health
Zelig Eshhar, Ph.D., Professor, Immunology, The Weizmann Institute of Science